Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average.
Left:
||||
Enterprise value to sales ratio
Latest
8.95
↓ 98% below average
Average (9y)
447.75
Historical baseline
Range
High:2341.72
Low:2.02
CAGR
+2.1%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 8.95 | -97.4% |
| 2023 | 350.44 | -85.0% |
| 2022 | 2341.72 | +36.3% |
| 2021 | 1718.40 | +15423.1% |
| 2020 | 11.07 | +447.2% |
| 2019 | 2.02 | -83.8% |
| 2018 | 12.45 | +15.5% |
| 2017 | 10.78 | -24.6% |
| 2016 | 14.30 | +93.0% |
| 2015 | 7.41 | - |